AI Empowered app to support the ADHD diagnosis

ADDHERE科技公司基于科学证据开发了一款人工智能应用程序，以支持对注意力缺陷多动障碍（ADHD）的诊断，特别是对儿童的诊断。注意缺陷多动障碍（ADHD）是儿童时期最常见的神经发育障碍之一，影响了世界上5%以上的儿童人口，但不幸的是，由于全球专家数量不足、分布不均以及他们目前使用的方法，80%的儿童永远不会得到诊断。注意缺陷多动障碍的终生累积损害得到强化，包括自杀风险更高、参与犯罪行为风险增加、药物滥用率高、焦虑和情绪障碍、人格障碍和破坏性障碍。通过早期诊断和治疗，ADHD的有害影响可能会大大减轻，但目前没有家庭、NHS或学校得到最低限度的指导和装备，以确保让家庭走上诊断的道路。该项目的目标是实现所有监管、隐私和安全要求，以巩固我们的App作为英国医疗设备的合规软件，这将使我们有信心与英国的学校和儿童进行验证，并使业务对投资者更具吸引力。

ADDHERE Technologies has developed an AI app, based on scientific evidence, to support the diagnosis of Attention Deficit Hyperactivity Disorder (ADHD), particularly in children. Attention Deficit Hyperactivity Disorder (ADHD) is one of the most common neurodevelopmental disorders in childhood, affecting more than 5% of the world's child population, but unfortunately 80% of them will never receive a diagnosis due to the insufficient number and poor distribution of specialists around the globe and the method they currently use. The cumulative lifetime impairment of ADHD is reinforced, including higher risk of suicide, increased risk of engaging in criminal behaviour, high rate of substance abuse, anxiety and mood disorders, personality disorders and disruptive disorders. The harmfull effects of ADHD might be considerable mitigated by early diagnosis and treatment, but currently not families, the NHS or schools are minimal instructed and equiped to assure put families on the diagnosis path way. This project goal is achieving all the regulatory, privacy and security requirements required to consolidate our App as a compliant software as a medical device in the UK with will enable us to confident doing validation with schools and children in the UK and turn the business still more attractive to investors.